Michael C Dennedy

Michael Conall Dennedy received the B.Sc. degree in pharmacology in 2000, the M.B., B.A.O., B.Ch. degree in 2002, the MD degree in obstetrics in 2007, and the Ph.D. degree in medicine in 2013. He is currently a Consultant Endocrinologist with Galway University Hospital, Galway, Ireland, and a Senior Lecturer in therapeutics with the National University of Ireland (NUI) Galway, Galway, Ireland. He trained through the HSE/HRB National SpR Academic Fellowship Programme, an integrated academic clinician scientist programme. Following this, he completed a fellowship in endocrinology with the University of Cambridge, Cambridge, U.K., and Addenbrooke's hospital. He assumed his current post in February 2014. His research interest focuses on the pathogenesis and treatment of functional adrenal tumors, both benign and malignant. He is a member of the European Network for the Study of Adrenal Tumour working Groups for adrenocortical carcinoma, aldosterone producing adenomas, phaeochromocytoma and non aldosterone producing adrenocortical adenomas. He retain links with the Institute of Metabolic Science, University of Cambridge, and has forged collaborations with Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, U.K. He is also affiliated with the CURAM programme, NUI, Galway and the Translational Medical Device Laboratory, Galway, Ireland. Dr. Dennedy is the Director for the Welcome/HRB Irish Clinical Academic Training (ICAT) Programme and the corecepient of this award. He is also the Director of the undergraduate MB/Ph.D. programme with NUI, Galway. He is the Specialty Director of endocrinology with the Royal College of Physicians of Ireland's, International Clinical Fellows Programme.